LAUREN BRENNAN: Open Payments
NPI 1790254068 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 114 payments from 11 companies in 2025. Trend: 2023 $1,965 · 2024 $1,560 · 2025 $1,848
Food & beverage: $1,848
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $383 |
| Otsuka America Pharmaceutical, Inc. | 26 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $251 |
| Teva Pharmaceuticals USA, Inc. | 11 | $241 |
| Janssen Pharmaceuticals, Inc | 12 | $228 |
| Alkermes, Inc. | 14 | $213 |
| ABBVIE INC. | 4 | $78 |
| Lundbeck LLC | 4 | $70 |
| Axsome Therapeutics, Inc. | 4 | $63 |
| Luye Pharma (USA) Ltd. | 3 | $41 |
Products named: INGREZZA, CAPLYTA, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.
Industry payments across OH — which companies pay providers there.
